Health officials in Kent have confirmed that the number of cases linked to the ongoing meningitis B outbreak has risen to 34 as of March 21, 2026. This total includes 23 laboratory-confirmed cases and 11 probable cases, with the UK Health Security Agency (UKHSA) maintaining that the death toll remains at two.
While the majority of those affected are students from the University of Kent and local sixth forms, the geographic reach of the cluster has subtly expanded, with a linked case identified at a higher education institution in London.
New genetic analysis has provided a significant breakthrough, confirming the outbreak is driven by a specific strain of Group B meningococci (sequence type 485) that is a direct match for the Bexsero vaccine currently being deployed. This confirmation has triggered a massive expansion of the public health response, with over 10,500 doses of antibiotics and 4,500 vaccinations already administered. Eligibility for the emergency jab has now been widened to include all students in years 12 and 13 at any Kent schools or colleges where a case has been identified, as well as anyone who visited the Club Chemistry nightclub in Canterbury between March 5 and its closure on March 15.
Despite the rise in figures, local health directors suggest the outbreak may be nearing its peak, noting that most new cases still trace back to the original exposure window in early March. However, officials remain on high alert for “secondary transmission”, where the bacteria spreads from an initial patient to a new contact, as students begin to travel home for the Easter break. To manage surging public anxiety and reports of private supply shortages, the government has released 20,000 doses from the national NHS stockpile into the private market to ensure pharmacies can meet the demand from those not covered by the official emergency rollout.